FDA Considers Meridia® Warning

Schmidt & Clark, LLP is No Longer Taking These Cases - If you feel that you may have a potential case, we urge you to contact another law firm adequately suited to handle your case.

This month, the FDA will decide the fate of the controversial diet pill Meridia®

Meridia FDA Warning Pending

On Sept. 1, 2010 the New England Journal of Medicine released an editorial calling for Meridia to be pulled from the market after a new study revealed an increased risk for heart attacks in some patients.

According to a report by CBS News medical correspondent Dr. Jonathan LaPook, the unusually critical editorial came as a result of the largest long-term study of Meridia. Almost 10,000 overweight or obese people with cardiovascular disease or diabetes were followed for three and a half years. The group taking Meridia lost on average about 9 lbs., but had a 16 percent higher risk of suffering a heart attack or stroke.

An FDA committee will meet later this month to decide Meridia’s fate.

Awards & recognition